Search | IOVS | ARVO Journals

Showing 1 – 20 of 54

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Human corneal lenticule bio-engineered with rhNGF and Mesenchymal Stromal Cells and its effect on pre-clinical models of glaucoma and diabetic retinopathy.

Letizia Pelusi; Luca Agnifili; Nadia Di Pietrantonio; Jose Hurst; Marcello Allegretti; Sven Schnichels; Leonardo Mastropasqua; Sveva Bollini; Mario Nubile; Assunta Pandolfi; Domitilla Mandatori

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3972.

ARVO Annual Meeting Abstract June 2024

Supercharged unfolded proteins (SUPs) as potential topical drug delivery systems

Sven Schnichels; Chiara Seiz; Tina-Marie Thomas; Andreas Herrmann; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3968.

ARVO Annual Meeting Abstract June 2024

Photobiomodulation as a potential neuroprotective therapy for oxidative stress in the retina

Jose Hurst; Agnes Fietz; Francesca Corsi; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3956.

ARVO Annual Meeting Abstract June 2023

More than just an adjuvant: Inhibition of neovascularization via DNA motifs

Jose Hurst; Julia Alber; Agnes Fietz; Peter Heiduschka; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):731.

ARVO Annual Meeting Abstract June 2023

Neuroprotection using a TrκB-Aptamer on the porcine retina

Isabell Schleicher; Sven Schnichels; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1608.

ARVO Annual Meeting Abstract June 2023

Blue light induces apoptosis in ex vivo retinal explants

agnes Fietz; José Hurst; Isabell Schleicher; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3876.

ARVO Annual Meeting Abstract June 2023

Friend or foe: The ambiguous role of RPE cells in retinal organ co-cultures

Sven Schnichels; Agnes Fietz; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3740.

ARVO Annual Meeting Abstract June 2022

Beneficial impact of primary RPE cells in a porcine organotypic co-cultivation model

Stephanie C Joachim; Natalie Wagner; Armin Safaei; Jose Hurst; Pia Vogt; Maurice R Gammel; H. Bukhard Dick; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):797 – F0356.

ARVO Annual Meeting Abstract June 2022

The expression of SARS-CoV 2 co-receptors and glia reaction in eyes of normal and COVID-19 diseased patients

Jose Hurst; Daniela Suesskind; Focke Ziemssen; Tarek Bayyoud; Sebastian Thaler; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2373 – A0057.

ARVO Annual Meeting Abstract June 2022

Customized magnetic nanopropellers grant targeted delivery to the retina

Sven Schnichels; Florian Peter; Vincent M Kadiri; Heidi Mühl; Marina Löscher; Peer Fischer; Jose Hurst

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4150 – F0142.

ARVO Annual Meeting Abstract June 2021

The expression of SARS-CoV 2-receptors in ocular tissue of normal and COVID-19 diseased patients

Sven Schnichels; Daniela Süsskind; Jens Martin Rohrbach; Tarek Bayyoud; Focke Ziemssen; Sebastian Thaler; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1963.

ARVO Annual Meeting Abstract June 2020

Evaluation of nanorobots for targeted delivery into the retina

Sven Schnichels; Rahul Goyal; José Hurst; Focke Ziemssen; Tian Qiu; Peer Fischer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1355.

ARVO Annual Meeting Abstract June 2020

Reduced apoptosis and autophagy in an oxidative stress retina organ culture model through an iNOS-inhibitor

Stephanie C Joachim; Ana Maria Müller-Bühl; Jose Hurst; Carsten Theiss; Lisa Hofmann; Laura Peters; Fenja Herms; Sandra Kuehn; H Burkhard Dick; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2473.

ARVO Annual Meeting Abstract June 2020

In vitro cellular toxicity of ILM dyes on human RPE and Müller glia cell lines

Karel Van Keer; James Burckhardt; José Hurst; Sven Schnichels; Koen Willekens; Peter Stalmans

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3116.

ARVO Annual Meeting Abstract July 2019

Establishment of an in vitro photoreceptor model suitable for AMD research

Natalie Wagner; Maurice Gammel; Sabrina Reinehr; Jose Hurst; Sven Schnichels; Burkhard Dick; Stephanie C Joachim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1339.

ARVO Annual Meeting Abstract July 2019

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Lisa Pohl; Nele Heider; Jose Hurst; Martin Prinz; Christine Hohenadl; Charlotte Reither; Kai Januschowski; Sven Schnichels; Martin Spitzer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6608.

ARVO Annual Meeting Abstract July 2019

Brimonidine loaded lipid DNA-nanoparticles as an improved and novel treatment option for glaucoma

Sven Schnichels; Katharina Frößl; Jan Willem de Vries; Marina Löscher; Karl Bartz-Schmidt; Andreas Herrmann; Martin S Spitzer; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1703.

ARVO Annual Meeting Abstract July 2019

iNOS-inhibitor treatment leads to cell rescue in a porcine retina organ culture model

Jose Hurst; Ana Maliha; Sandra Kuehn; Fenja Herms; Sven Schnichels; Stephanie C Joachim

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4873.

ARVO Annual Meeting Abstract July 2019

Potential therapy of neurodegenerative retinopathies via activation of the BDNF-TrkB signaling pathway by a specific aptamer

Marina Löscher; Evangelia Lilou; Karl Ulrich Bartz-Schmidt; Sven Schnichels; José Hurst

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5708.

ARVO Annual Meeting Abstract July 2019

Neuroprotective effects via hypothermia on hydrogen peroxide damaged porcine retinae

Stephanie C Joachim; Ana Maliha; Sven Grauthoff; Sandra Kuehn; Jose Hurst; Hannah Doepper; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5721.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Human corneal lenticule bio-engineered with rhNGF and Mesenchymal Stromal Cells and its effect on pre-clinical models of glaucoma and diabetic retinopathy.

Supercharged unfolded proteins (SUPs) as potential topical drug delivery systems

Photobiomodulation as a potential neuroprotective therapy for oxidative stress in the retina

More than just an adjuvant: Inhibition of neovascularization via DNA motifs

Neuroprotection using a TrκB-Aptamer on the porcine retina

Blue light induces apoptosis in ex vivo retinal explants

Friend or foe: The ambiguous role of RPE cells in retinal organ co-cultures

Beneficial impact of primary RPE cells in a porcine organotypic co-cultivation model

The expression of SARS-CoV 2 co-receptors and glia reaction in eyes of normal and COVID-19 diseased patients

Customized magnetic nanopropellers grant targeted delivery to the retina

The expression of SARS-CoV 2-receptors in ocular tissue of normal and COVID-19 diseased patients

Evaluation of nanorobots for targeted delivery into the retina

Reduced apoptosis and autophagy in an oxidative stress retina organ culture model through an iNOS-inhibitor

In vitro cellular toxicity of ILM dyes on human RPE and Müller glia cell lines

Establishment of an in vitro photoreceptor model suitable for AMD research

Thiolated cross-linked hydrogel as a vitreous substitute – a 6-month follow-up study

Brimonidine loaded lipid DNA-nanoparticles as an improved and novel treatment option for glaucoma

iNOS-inhibitor treatment leads to cell rescue in a porcine retina organ culture model

Potential therapy of neurodegenerative retinopathies via activation of the BDNF-TrkB signaling pathway by a specific aptamer

Neuroprotective effects via hypothermia on hydrogen peroxide damaged porcine retinae

To View More...

You must be signed into an individual account to use this feature.